BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 20688117)

  • 1. Solid-phase peptide head-to-side chain cyclodimerization: discovery of C(2)-symmetric cyclic lactam hybrid α-melanocyte-stimulating hormone (MSH)/agouti-signaling protein (ASIP) analogues with potent activities at the human melanocortin receptors.
    Mayorov AV; Cai M; Palmer ES; Liu Z; Cain JP; Vagner J; Trivedi D; Hruby VJ
    Peptides; 2010 Oct; 31(10):1894-905. PubMed ID: 20688117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic lactam hybrid α-MSH/Agouti-related protein (AGRP) analogues with nanomolar range binding affinities at the human melanocortin receptors.
    Mayorov AV; Cai M; Palmer ES; Tanaka DK; Cain JP; Dedek MM; Tan B; Trivedi D; Hruby VJ
    Bioorg Med Chem Lett; 2011 May; 21(10):3099-102. PubMed ID: 21486697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors.
    Hruby VJ; Lu D; Sharma SD; Castrucci AL; Kesterson RA; al-Obeidi FA; Hadley ME; Cone RD
    J Med Chem; 1995 Sep; 38(18):3454-61. PubMed ID: 7658432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of cyclic lactam analogues of alpha-melanocyte-stimulating hormone (alpha-MSH) targeting the human melanocortin-3 receptor.
    Mayorov AV; Cai M; Palmer ES; Dedek MM; Cain JP; Van Scoy AR; Tan B; Vagner J; Trivedi D; Hruby VJ
    J Med Chem; 2008 Jan; 51(2):187-95. PubMed ID: 18088090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel agouti-related-protein-based melanocortin-1 receptor antagonist.
    Thirumoorthy R; Holder JR; Bauzo RM; Richards NG; Edison AS; Haskell-Luevano C
    J Med Chem; 2001 Nov; 44(24):4114-24. PubMed ID: 11708914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric NDP-MSH and MTII melanocortin peptides with agouti-related protein (AGRP) Arg-Phe-Phe amino acids possess agonist melanocortin receptor activity.
    Joseph CG; Wilczynski A; Holder JR; Xiang Z; Bauzo RM; Scott JW; Haskell-Luevano C
    Peptides; 2003 Dec; 24(12):1899-908. PubMed ID: 15127941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of new cyclic melanotropin peptide analogues selective for the human melanocortin-4 receptor.
    Ying J; Gu X; Cai M; Dedek M; Vagner J; Trivedi DB; Hruby VJ
    J Med Chem; 2006 Nov; 49(23):6888-96. PubMed ID: 17154518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity studies of the melanocortin peptides: discovery of potent and selective affinity antagonists for the hMC3 and hMC4 receptors.
    Grieco P; Lavecchia A; Cai M; Trivedi D; Weinberg D; MacNeil T; Van der Ploeg LH; Hruby VJ
    J Med Chem; 2002 Nov; 45(24):5287-94. PubMed ID: 12431055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional properties of an agouti signaling protein variant and characteristics of its cognate radioligand.
    Yang YK; Dickinson C; Lai YM; Li JY; Gantz I
    Am J Physiol Regul Integr Comp Physiol; 2001 Dec; 281(6):R1877-86. PubMed ID: 11705773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of recombinant agouti-signaling protein on melanocortin action.
    Yang YK; Ollmann MM; Wilson BD; Dickinson C; Yamada T; Barsh GS; Gantz I
    Mol Endocrinol; 1997 Mar; 11(3):274-80. PubMed ID: 9058374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further structure-activity studies of lactam derivatives of MT-II and SHU-9119: their activity and selectivity at human melanocortin receptors 3, 4, and 5.
    Grieco P; Cai M; Han G; Trivedi D; Campiglia P; Novellino E; Hruby VJ
    Peptides; 2007 Jun; 28(6):1191-6. PubMed ID: 17482720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R.
    Haskell-Luevano C; Hendrata S; North C; Sawyer TK; Hadley ME; Hruby VJ; Dickinson C; Gantz I
    J Med Chem; 1997 Jul; 40(14):2133-9. PubMed ID: 9216831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of cyclic gamma-MSH analogues with selective hMC3R agonist and hMC3R/hMC5R antagonist activities.
    Mayorov AV; Cai M; Chandler KB; Petrov RR; Van Scoy AR; Yu Z; Tanaka DK; Trivedi D; Hruby VJ
    J Med Chem; 2006 Mar; 49(6):1946-52. PubMed ID: 16539382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microwave-assisted solid-phase synthesis of side-chain to side-chain lactam-bridge cyclic peptides.
    Tala SR; Schnell SM; Haskell-Luevano C
    Bioorg Med Chem Lett; 2015 Dec; 25(24):5708-11. PubMed ID: 26555357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agouti antagonism of melanocortin-4 receptor: greater effect with desacetyl-alpha-melanocyte-stimulating hormone (MSH) than with alpha-MSH.
    Mountjoy KG; Willard DH; Wilkison WO
    Endocrinology; 1999 May; 140(5):2167-72. PubMed ID: 10218968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach.
    Han G; Haskell-Luevano C; Kendall L; Bonner G; Hadley ME; Cone RD; Hruby VJ
    J Med Chem; 2004 Mar; 47(6):1514-26. PubMed ID: 14998337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Functional Alanine Positional Scanning of the α-Melanocyte Stimulating Hormone and NDP-Melanocyte Stimulating Hormone Demonstrates Differential Structure-Activity Relationships at the Mouse Melanocortin Receptors.
    Todorovic A; Ericson MD; Palusak RD; Sorensen NB; Wood MS; Xiang Z; Haskell-Luevano C
    ACS Chem Neurosci; 2016 Jul; 7(7):984-94. PubMed ID: 27135265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topographical modification of melanotropin peptide analogues with beta-methyltryptophan isomers at position 9 leads to differential potencies and prolonged biological activities.
    Haskell-Luevano C; Boteju LW; Miwa H; Dickinson C; Gantz I; Yamada T; Hadley ME; Hruby VJ
    J Med Chem; 1995 Nov; 38(23):4720-9. PubMed ID: 7473600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inverse agonist activity of agouti and agouti-related protein.
    Chai BX; Neubig RR; Millhauser GL; Thompson DA; Jackson PJ; Barsh GS; Dickinson CJ; Li JY; Lai YM; Gantz I
    Peptides; 2003 Apr; 24(4):603-9. PubMed ID: 12860205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.